Cancer
-
Introducing BRIDGE: A life- changing gift advancing research and treatment for a rare form of bowel cancer
Posted on:
The University of Sydney and the Kolling Institute have launched a groundbreaking research program to transform treatment for one of the most aggressive forms of bowel cancer. Supported by a $1.3 million philanthropic gift, the BRIDGE program offers new hope for patients with BRAFv600e‑mutated bowel cancer. This mutation, present in around 10 per cent of
Category:
-
The Kolling welcomes Australia’s leading genomics provider to the institute
Posted on:
Researchers within the Kolling Institute will shortly have the chance to strengthen their genomics capabilities, with AGRF – the Australian Genome Research Facility – establishing a laboratory within the institute. The new lab is part of an exciting partnership between AGRF, the University of Sydney and the Kolling which will see a specialised team and
-
September 2025 Kolling NEWS
Posted on:
Our latest Kolling Institute newsletter is out detailing the very latest updates from our expert team of researchers, including some promising progress with our bowel cancer investigators. There’s an opportunity to join a clinical trial to minimise the impact of osteoarthritis, a new approach to reduce spinal cord injury related pain and an international award recognising 40
-
Game-changing blood test to detect bowel cancer
Posted on:
Bowel cancer is the third most common type of cancer in Australia and treating it is both costly and complex. Alarmingly, rates are rising among people under 50, and researchers still don’t know why. It is for these reasons that Professor Mark Molloy is on a mission to prevent the disease in the first place. Based
Category:
-
Podcast offers insight into the future of healthcare
Posted on:
A fascinating and informative podcast has been launched showcasing groundbreaking research, innovative healthcare, and inspiring stories from across Northern Sydney. Tomorrow’s Medicine Today is an initiative of the Northern Sydney Local Health District and the Kolling Institute, New South Wales’ oldest medical research institute. Co-hosted by the Kolling Institute’s Academic Director Professor James Elliott and leading
-
Celebrating over 100 years of innovation
Posted on:
The inaugural Eva Kolling Research Day was staged within Royal North Shore Hospital, providing the perfect chance to celebrate the vision and generosity of a true pioneer. Established in 1920, the Kolling Institute is the oldest medical research institute in New South Wales. It has been at the forefront of cutting-edge research for more than
-
Improving cancer detection in young people with neurofibromatosis type 1
Posted on:
Researchers from Royal North Shore Hospital and the Kolling Institute will lead Australia’s first study of whole-body screening for young people with neurofibromatosis type 1. Led by Dr Sue-Faye Siow from the department of clinical genetics, the study was awarded a grant through the RNSH Campus Research Grants Scheme, and an additional $30,000 in support
Category:
-
-
Multi-million dollar grant to improve treatment for lung cancer
Posted on:
Leading Royal North Shore Hospital clinician researcher Professor Nick Pavlakis and Professor Ben Solomon have secured a $14.7 million MRFF grant for a clinical trial which will explore the use of a liquid biopsy to inform treatment for lung cancer. The condition is the leading cause of cancer death in Australia and worldwide, claiming an
Category:
-
Prestigious grant for groundbreaking blood cancer research at the Kolling
Posted on:
A two-decade long commitment to reducing blood cancers has delivered coveted national funding to Associate Professor Jenny Wang to progress her vital cancer research. As the head of the Kolling Institute’s Cancer and Stem Cell Laboratory, Associate Professor Wang has secured a $2.95 million investigator grant from the National Health and Medical Research Council to
Category:
Copyright © 2026 Kolling Institute
All rights reserved